share_log

SciBase Partners With Al Shirawi Healthcare Solutions to Offer Nevisense in UAE

SciBase Partners With Al Shirawi Healthcare Solutions to Offer Nevisense in UAE

SciBase 與 Al Shirawi 醫療保健解決方案合作,在阿聯酋提供 Nevisense
PR Newswire ·  04/24 14:25

STOCKHOLM, April 24, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders is pleased to announce a new partnership with Al Shirawi Healthcare solutions, a leading distributor of medical technologies across multiple specialities of aesthetics dermatology, orthopedics and medical consumables In Dubai. Through this partnership, Nevisense will now be available for patients in the United Arab Emirates (UAE).

斯德哥爾摩,2024 年 4 月 24 日 /PRNewswire/ — SciBase Holding AB(“SciBase”) (停止:SCIB),基於增強智能的皮膚病解決方案的領先開發商 很高興地宣佈與Al Shirawi Healthcare solutions建立新的合作伙伴關係,Al Shirawi Healthcare solutions是迪拜美容皮膚科、骨科和醫療耗材等多個專業領域的領先醫療技術分銷商。通過這種夥伴關係,Nevisense現在將可供阿拉伯聯合酋長國(阿聯酋)的患者使用。

Skin cancer is a growing problem in the UAE with official statistics suggesting that skin cancer accounts for about 14.5 per cent of cancer cases among males.

在阿聯酋,皮膚癌是一個日益嚴重的問題,官方統計數據表明,皮膚癌約佔男性癌症病例的14.5%。

"We see the UAE as an attractive market with a passion for state-of-the-art, groundbreaking technologies. Partnering up with a well-resourced and knowledgeable ally will enable quick market access at a low investment cost. We see this as a way to increase our reach and help more people receive the best care possible," says Pia Renaudin, CEO at SciBase

“我們將阿聯酋視爲一個有吸引力的市場,對最先進的開創性技術充滿熱情。與資源充足、知識淵博的盟友合作將以較低的投資成本快速進入市場。我們認爲這是擴大覆蓋面並幫助更多人獲得儘可能好的醫療服務的一種方式。” SciBase首席執行官皮亞·雷諾丁說

"SciBase is an ideal partner as their technology fits perfectly with our goals and principles. We're dedicated to offering our customers the best tools possible to improve patient care, and Nevisense is a clear choice to help us achieve that," says Ahmed Ismail. General manager at Al Shirawi Healthcare solutions

“SciBase 是理想的合作伙伴,因爲他們的技術完全符合我們的目標和原則。我們致力於爲客戶提供儘可能好的工具來改善患者護理,而Nevisense是幫助我們實現這一目標的明智選擇,” 艾哈邁德·伊斯梅爾說。Al Shirawi 醫療保健解決方案總經理

For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]

欲了解更多信息,請聯繫:
Pia Renaudin,VD,電話 +46732069802,電子郵件:[email protected]

Certified Advisor (CA):
Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]

認證顧問 (CA):
Vator 證券
電話:+46 8 580 065 99
電子郵件:[電子郵件保護]

About Al Shirawi Healthcare solutions

關於 Al Shirawi 醫療保健解決方案

Established to provide the Middle East market with advanced medical technologies across multiple specialities of aesthetics dermatology, orthopedics and medical consumables, Al Shirawi Healthcare, a part of the reputed Al Shirawi Group, provides an extensive array of turnkey solutions that combine safety with efficacy to enable healthcare providers to deliver a level of extraordinary care.

Al Shirawi Healthcare是著名的Al Shirawi Group旗下公司,旨在爲中東市場提供美容皮膚科、骨科和醫療耗材等多個專業領域的先進醫療技術,提供廣泛的統包解決方案,將安全性與療效相結合,使醫療保健提供者能夠提供一定水平的卓越護理。

An ISO-certified company headquartered in the heart of Dubai, Al Shirawi Healthcare is powered by highly-skilled teams across Sales and specialised Marketing, Regulatory Affairs, Customer Service and Coordination, After Sales Services, Tendering, Training and Education Department as well as a Quality Control and Auditing Department, enabling it to meet and exceed client expectations through its unprecedented in-house resources and commitment to excellence.

Al Shirawi Healthcare是一家總部位於迪拜市中心的ISO認證公司,由銷售和專業營銷、監管事務、客戶服務和協調、售後服務、招標、培訓和教育部門以及質量控制和審計部門的高技能團隊提供支持,使其能夠通過其前所未有的內部資源和對卓越的承諾來滿足和超越客戶的期望。

About SciBase:

關於 SciBase:

SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.

SciBase 是一家全球醫療技術公司,專門從事皮膚病學的早期發現和預防。SciBase 開發並商業化了 Nevisense,這是一個獨特的即時護理平台,它結合了人工智能(人工智能)和先進的 EIS 技術,可提高診斷準確性,確保積極的皮膚健康管理。

Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.

我們的承諾是最大限度地減少患者的痛苦,使臨床醫生能夠通過及時的檢測和干預來改善和挽救生命,並降低醫療成本。

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.

SciBase建立在瑞典斯德哥爾摩卡羅林斯卡研究所20多年的研究基礎上,是皮膚病學進步領域的領導者。

The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at . All press releases and financial reports can be found here:

該公司自2015年6月2日起在納斯達克第一北方成長市場交易所上市。要了解更多,請訪問。所有新聞稿和財務報告都可以在這裏找到:

This information was brought to you by Cision

這些信息是由 Cision 帶給你的

The following files are available for download:

以下文件可供下載:

Dubai PR final

迪拜公關決賽

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論